CME Group's Terry Duffy to Step Down as CEO, Lynne Fitzpatrick to Take Helm

Terry Duffy, CEO of CME Group, will transition to Executive Chairman in March 2027, making way for Lynne Fitzpatrick, the company's President and CFO, to become the new CEO. The change is set to take place in 2027. The company has named Lynne Fitzpatrick as Duffy's successor, marking a significant change in leadership.

Terry Duffy, who has led CME Group for over two decades, will step down as CEO effective March 1, 2027, transitioning to the role of Executive Chairman of the Board through December 31, 2027. The announcement closes a landmark tenure for Duffy, who became CME's chairman in 2002 and guided the company through its transformation from a member-owned exchange into the world's leading derivatives marketplace by open interest and notional volume.

Succeeding Duffy is Lynne Fitzpatrick, CME's current President and CFO and a 20-year company veteran. Fitzpatrick, who took on the dual President-CFO role in 2022, will become CEO on March 1, 2027 and join the Board upon her appointment. She will be the first woman to lead CME Group in its 174-year history.

The planned overlap period, with Duffy serving as Executive Chairman through end of 2027, gives Fitzpatrick a transition runway. Investors will watch whether her capital allocation priorities differ from Duffy's and whether any pending strategic acquisitions or product expansions accelerate under new leadership. Orderly insider succession in exchange operators has historically been well-received by markets, as it preserves institutional continuity while signaling long-term confidence in the bench.